Outlook: BioNTech reports figures for the latest quarter

taketonews

BioNTech (ADRs) will open the books for the past quarter ended 6/30/2022 at its quarter-end financial conference on 8/8/2022.

The estimates of 10 analysts assume an average EPS of EUR 7.08 per share. In the prior-year quarter, BioNTech (ADRs) earned EUR 10.77 per share.

In terms of sales, 8 analysts expect a decrease of 26.83 percent compared to the same quarter of the previous year. Expectations here are an average of EUR 3.88 billion compared to EUR 5.31 billion in the same period of the previous year.

14 analysts provide an outlook for the current fiscal year. They forecast earnings of EUR 34.92 per share on average, compared to EUR 39.63 per share in the same period last year. 15 analysts saw annual sales at an average of EUR 16.51 billion. In the previous year, EUR 18.98 billion had been generated.

Editorial office finanzen.net

Selected Leverage Products on BioNTech (ADRs)With knock-outs, speculative investors can participate disproportionately in price movements. Simply select the desired lever and we will show you suitable open-end products on BioNTech (ADRs)

Leverage must be between 2 and 20

No data

More news about BioNTech (ADRs)

Image sources: Thomas Lohnes/Getty Images, Pavlo Gonchar/SOPA Images/LightRocket via Getty Images

ttn-28